Pharmacogenomics and Personalized Medicine:
With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, lead...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2008
|
Schriftenreihe: | Methods in Pharmacology and Toxicology
|
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting a realistic perspective on the challenges, practicalities and obstacles in its application. Focusing on DNA data and associated analytical methodologies this volume includes a wide array of vital, cutting-edge research. Comprehensive and timely, Pharmacogenomics and Personalized Medicine will assist novice and experienced investigators alike in the understanding of the current scientific challenges in applying pharmacogenomics to drug discovery and clinical development |
Beschreibung: | 1 Online-Ressource (XVI, 509 p. 53 illus) |
ISBN: | 9781597454391 |
DOI: | 10.1007/978-1-59745-439-1 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044950828 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 180517s2008 |||| o||u| ||||||eng d | ||
020 | |a 9781597454391 |9 978-1-59745-439-1 | ||
024 | 7 | |a 10.1007/978-1-59745-439-1 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-59745-439-1 | ||
035 | |a (OCoLC)712419215 | ||
035 | |a (DE-599)BVBBV044950828 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
082 | 0 | |a 615 |2 23 | |
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
245 | 1 | 0 | |a Pharmacogenomics and Personalized Medicine |c edited by Nadine Cohen |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2008 | |
300 | |a 1 Online-Ressource (XVI, 509 p. 53 illus) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods in Pharmacology and Toxicology | |
520 | |a With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting a realistic perspective on the challenges, practicalities and obstacles in its application. Focusing on DNA data and associated analytical methodologies this volume includes a wide array of vital, cutting-edge research. Comprehensive and timely, Pharmacogenomics and Personalized Medicine will assist novice and experienced investigators alike in the understanding of the current scientific challenges in applying pharmacogenomics to drug discovery and clinical development | ||
650 | 4 | |a Biomedicine | |
650 | 4 | |a Pharmacology/Toxicology | |
650 | 4 | |a Human Genetics | |
650 | 4 | |a Medicine | |
650 | 4 | |a Human genetics | |
650 | 4 | |a Pharmacology | |
700 | 1 | |a Cohen, Nadine |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781934115046 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-59745-439-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030343587 | ||
966 | e | |u https://doi.org/10.1007/978-1-59745-439-1 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-59745-439-1 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178538732978176 |
---|---|
any_adam_object | |
author2 | Cohen, Nadine |
author2_role | edt |
author2_variant | n c nc |
author_facet | Cohen, Nadine |
building | Verbundindex |
bvnumber | BV044950828 |
classification_rvk | QR 525 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-59745-439-1 (OCoLC)712419215 (DE-599)BVBBV044950828 |
dewey-full | 615 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615 |
dewey-search | 615 |
dewey-sort | 3615 |
dewey-tens | 610 - Medicine and health |
discipline | Wirtschaftswissenschaften Medizin |
doi_str_mv | 10.1007/978-1-59745-439-1 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02524nmm a2200457zc 4500</leader><controlfield tag="001">BV044950828</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781597454391</subfield><subfield code="9">978-1-59745-439-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-59745-439-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-59745-439-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)712419215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044950828</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacogenomics and Personalized Medicine</subfield><subfield code="c">edited by Nadine Cohen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVI, 509 p. 53 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Pharmacology and Toxicology</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting a realistic perspective on the challenges, practicalities and obstacles in its application. Focusing on DNA data and associated analytical methodologies this volume includes a wide array of vital, cutting-edge research. Comprehensive and timely, Pharmacogenomics and Personalized Medicine will assist novice and experienced investigators alike in the understanding of the current scientific challenges in applying pharmacogenomics to drug discovery and clinical development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Nadine</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781934115046</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-59745-439-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030343587</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59745-439-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59745-439-1</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV044950828 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:05:34Z |
institution | BVB |
isbn | 9781597454391 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030343587 |
oclc_num | 712419215 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (XVI, 509 p. 53 illus) |
psigel | ZDB-2-PRO |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Humana Press |
record_format | marc |
series2 | Methods in Pharmacology and Toxicology |
spelling | Pharmacogenomics and Personalized Medicine edited by Nadine Cohen Totowa, NJ Humana Press 2008 1 Online-Ressource (XVI, 509 p. 53 illus) txt rdacontent c rdamedia cr rdacarrier Methods in Pharmacology and Toxicology With all of the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting a realistic perspective on the challenges, practicalities and obstacles in its application. Focusing on DNA data and associated analytical methodologies this volume includes a wide array of vital, cutting-edge research. Comprehensive and timely, Pharmacogenomics and Personalized Medicine will assist novice and experienced investigators alike in the understanding of the current scientific challenges in applying pharmacogenomics to drug discovery and clinical development Biomedicine Pharmacology/Toxicology Human Genetics Medicine Human genetics Pharmacology Cohen, Nadine edt Erscheint auch als Druck-Ausgabe 9781934115046 https://doi.org/10.1007/978-1-59745-439-1 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Pharmacogenomics and Personalized Medicine Biomedicine Pharmacology/Toxicology Human Genetics Medicine Human genetics Pharmacology |
title | Pharmacogenomics and Personalized Medicine |
title_auth | Pharmacogenomics and Personalized Medicine |
title_exact_search | Pharmacogenomics and Personalized Medicine |
title_full | Pharmacogenomics and Personalized Medicine edited by Nadine Cohen |
title_fullStr | Pharmacogenomics and Personalized Medicine edited by Nadine Cohen |
title_full_unstemmed | Pharmacogenomics and Personalized Medicine edited by Nadine Cohen |
title_short | Pharmacogenomics and Personalized Medicine |
title_sort | pharmacogenomics and personalized medicine |
topic | Biomedicine Pharmacology/Toxicology Human Genetics Medicine Human genetics Pharmacology |
topic_facet | Biomedicine Pharmacology/Toxicology Human Genetics Medicine Human genetics Pharmacology |
url | https://doi.org/10.1007/978-1-59745-439-1 |
work_keys_str_mv | AT cohennadine pharmacogenomicsandpersonalizedmedicine |